financetom
Business
financetom
/
Business
/
Market Chatter: Apple Readies Changes to Displays of MacBook Air, iPad Air, iPad Mini
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Apple Readies Changes to Displays of MacBook Air, iPad Air, iPad Mini
Oct 29, 2025 6:10 AM

08:59 AM EDT, 10/29/2025 (MT Newswires) -- Apple ( AAPL ) is planning to give higher-end displays to its MacBook Air, iPad Air and iPad mini lines, Bloomberg reported Wednesday, citing people with knowledge of the matter.

New versions of each device are being tested with organic light-emitting diode screens, with the iPad mini likely the first to be upgraded, the people said.

An iPad mini equipped with OLED could be rolled out as early as 2026 and cost up to $100 more due to the more expensive display, according to the report.

The company has yet to finalize the upgrade plans, which it could change or be postponed, the report said.

Apple ( AAPL ) didn't immediately respond to a request for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says
Oct 4, 2024
JMP Securities initiated coverage on Enovis Corporation ( ENOV ) , a medical technology company focusing on orthopedics. The analyst adds that the company sells a broad portfolio of products, many of which were added via selective acquisitions (around 20 over the last 4.5 years). The analyst views M&A as a core competency. The company’s product offerings span large joint...
Corcept Therapeutics Insider Sold Shares Worth $462,800, According to a Recent SEC Filing
Corcept Therapeutics Insider Sold Shares Worth $462,800, According to a Recent SEC Filing
Oct 4, 2024
04:34 PM EDT, 10/03/2024 (MT Newswires) -- William Guyer, Chief Development Officer, on October 01, 2024, sold 10,000 shares in Corcept Therapeutics ( CORT ) for $462,800. Following the Form 4 filing with the SEC, Guyer has control over a total of 5,796 shares of the company, with 5,796 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1088856/000095017024112385/xslF345X05/ownership.xml ...
Progress Software Insider Sold Shares Worth $537,916, According to a Recent SEC Filing
Progress Software Insider Sold Shares Worth $537,916, According to a Recent SEC Filing
Oct 4, 2024
04:26 PM EDT, 10/03/2024 (MT Newswires) -- Yogesh K Gupta, Director, Chief Executive Officer, on October 01, 2024, sold 8,028 shares in Progress Software ( PRGS ) for $537,916. Following the Form 4 filing with the SEC, Gupta has control over a total of 148,245 shares of the company, with 148,245 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/876167/000087616724000153/xslF345X05/wk-form4_1727986619.xml Price: 64.29, Change:...
Procter & Gamble Insider Sold Shares Worth $763,346, According to a Recent SEC Filing
Procter & Gamble Insider Sold Shares Worth $763,346, According to a Recent SEC Filing
Oct 4, 2024
04:35 PM EDT, 10/03/2024 (MT Newswires) -- Jennifer L. Davis, CEO, Health Care, on October 01, 2024, sold 4,447 shares in Procter & Gamble ( PG ) for $763,346. Following the Form 4 filing with the SEC, Davis has control over a total of 67,370 shares of the company, with 52,872 shares held directly and 14,498 controlled indirectly. SEC Filing:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved